CYNAPSUS

Sublingual thin filmstrip of apomorphine to treat Parkinson's Disease OFF hypomobility episodes; pharmaceutical preparations for the treatment of Parkinson's Disease OFF hypomobility episodes, delivered orally via a sublingual thin filmstrip; therapeutic preparations to manage Parkinson's Disease OFF hypomobility episodes, delivered orally via a sublingual thin filmstrip; pharmaceutical preparations for the treatment of Parkinson's Disease; therapeutic pharmaceutical preparations for the treatment of Parkinson's Disease; pharmaceutical preparations for the treatment of the central nervous system, namely central nervous system movement disorders and infections, and brain diseases; therapeutic pharmaceutical preparations for the treatment of the central nervous system, namely central nervous system movement disorders and infections, and brain diseases; pharmaceutical preparations acting on the central nervous system; therapeutic pharmaceutical preparations acting on the central nervous system; drug delivery agents in the form of sublingual filmstrips to facilitate delivery of a wide range of prescription pharmaceuticals by providing release of active ingredients

Research and development of medicines and vaccines in the field of central nervous system pharmaceuticals; pharmaceutical research and development; research and development of medicines

Providing information regarding Parkinson's disease and Parkinson's disease OFF hypomobility episodes; providing information in the field of central nervous system disorders, infections, and diseases